Enhancer ID: | E_02_0663 |
Species: | human |
Position : | chr7:22723271-22725271 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Neurological disease |
Pubmed ID: | 31368839 |
Enhancer experiment: | PCR, flow cytometry |
Enhancer experiment description: | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
Target gene : | IL6,IL10 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b).;The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
TF name : | -- |
TF experiment: | PCR,????? |
TF experiment description: | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b).;The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
Enhancer function : | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|